No Data
No Data
Spot information on individual stocks (1)
InterAct <7725.T> surges. The consolidated operating profit forecast for the fiscal year ending in May has been increased from 1 billion yen to 1.3 billion yen (a 17% decrease compared to the previous year). IoT (Internet of Things) related segments are performing well. PRTIME <3922.T> sees a significant rise. The consolidated operating profit from September to November last year reached a record high for the first time in four quarters. Watts <2735.T> continues to rise significantly. The consolidated operating profit for the first quarter of the fiscal year ending in August (from September to November last year) was 270 million yen (a 40% increase compared to the same period last year). Presans <3254.T> (supervision) is.
PRTIMES, Giken Production Co., Ltd., Sunwells, ETC.
<6289> Giken Seisakusho 1489 -198 sharp drop. Last week, the first quarter financial results were announced, showing an operating profit of 0.65 billion yen, which is a substantial decrease of 46.2% compared to the previous period. The unchanged mid-term plan is 2.55 billion yen, indicating a 5.5% increase, resulting in an unexpectedly sluggish Start. Domestically, product sales decreased due to a reduction in construction scale caused by rising costs, and Overseas sales were affected by a reactionary decline from product sales recorded in Singapore and Brazil in the previous period. The reactionary decline in high operating profit margin products is also significantly decreased.
Stocks that hit the upper or lower limit in the afternoon session.
■ Limit Up <3254> Presan Corporation <4370> Mobilu <4421> D.I. System <4889> Renascience <5247> BTM <6255> N.P.C ■ Limit Down <244A> Growth Expert Partners <274A> Garden <3267> Phil Company <9229> Sanwells *Includes temporary limit up and down (indicative prices).
Stocks that moved or were traded in the first half of the session.
*PR TIMES <3922> raised its operating profit Financial Estimates for 2018 by +27,625. *Inter Action <7725> 1100 +108 revised its full-year forecast upward due to significant profit increase in the first half. *Cosmos Pharmaceutical <3349> 7347 +4529 landed above market expectations for the November term results. *Ryohin Keikaku <7453> 3744 +209 received positive evaluations for its first quarter financial results exceeding expectations. *M3 <2413> 1459.5 +49.5 Merrill Lynch.
Presance - The stock hits the upper limit buy indication, Open House is executing a TOB for complete acquisition.
Presans <3254> is showing a buying demand at the daily limit. The parent company, Open House Group, announced that it will execute a tender offer with the aim of full acquisition. The company has expressed support for this initiative and is recommending participation, aiming for a complete alignment with the tender offer price of 2390 yen. The tender offer price represents a 22.1% premium over last Friday's closing price. The tender offer period is set from January 14 to February 26.
Open House to Acquire Remaining Stake in Pressance for Full Control
No Data